The biologics CDMO (Contract Development and Manufacturing Organization) secondary packaging market has witnessed significant growth, with a projected market size of US$ 5.50 billion by 2034, up from US$ 2.38 billion in 2024. This rapid growth is expected to occur at a compound annual growth rate (CAGR) of 8.75% from 2024 to 2034, driven by several factors including the increasing prevalence of chronic diseases, the rise in demand for biologics, and advancements in packaging technologies.
https://www.towardspackaging.com/insights/biologics-cdmo-secondary-packaging-market-sizing
https://www.towardspackaging.com/insights/biologics-cdmo-secondary-packaging-market-sizing
The biologics CDMO secondary packaging market is vital to ensuring the safety, integrity, and protection of biologics, especially temperature-sensitive drugs such as vaccines, gene therapies, and monoclonal antibodies. Secondary packaging plays a crucial role in the transportation and storage of biologics, ensuring that the drugs maintain the required temperature throughout their distribution lifecycle. The market’s growth is largely attributed to the expansion of the biologics industry and the rising demand for outsourcing services in drug development and manufacturing.
Key packaging solutions such as cartonization, labeling, and other post-primary packaging processes are essential for protecting biologics. These packaging techniques are crucial for safeguarding drugs like syringes, vaccine vials, and other biological products. With the rising focus on biological therapies, such as biosimilars, gene therapy, and monoclonal antibodies, the biologics CDMO secondary packaging market is poised for further expansion.
A significant driver of growth in the biologics CDMO secondary packaging market is the increasing collaboration between companies. The growing demand for risk-free, secure storage, and transportation of biologic drugs has led to partnerships that focus on innovation in packaging materials and techniques. Secondary packaging ensures that biologic drugs are stored under controlled conditions, maintaining their integrity and efficacy. Cold chain logistics, which is essential for transporting temperature-sensitive biologics, is becoming more complex, pushing companies to adopt advanced packaging solutions.
The need for temperature-regulated packaging, including insulated packaging, frozen ampoules, and temperature-intensive care systems, is driving the development of new and innovative secondary packaging solutions. The market is also witnessing a shift toward sustainable, environmentally friendly packaging materials, as the pharmaceutical industry seeks to reduce its environmental footprint.
Furthermore, the integration of automation and smart packaging solutions is transforming the biologics CDMO secondary packaging market. Smart packaging helps in tracking and monitoring the conditions of biologics during transportation, ensuring that temperature and storage conditions remain optimal.
North America led the biologics CDMO secondary packaging market in 2023, driven by the region’s strong pharmaceutical manufacturing capabilities and advanced healthcare infrastructure. The U.S. and Canada are key markets for biologic drugs due to the high prevalence of chronic diseases such as diabetes and infectious diseases, which increase the demand for biologics. The region also boasts the presence of major market players and is home to robust healthcare systems that fuel the demand for secure and reliable secondary packaging solutions.
Asia Pacific is expected to witness the highest CAGR during the forecast period. The region is experiencing rapid advancements in healthcare, with governments in countries like China, Japan, India, Thailand, and South Korea investing heavily in the healthcare sector. This has led to an increase in pharmaceutical production and a rising demand for cost-effective, high-quality packaging solutions. Additionally, the growing number of diseases and a rising demand for biologics are expected to drive the growth of the biologics CDMO secondary packaging market in this region.
The boxes segment dominated the biologics CDMO secondary packaging market in 2023. This segment continues to grow due to the ability of boxes to store large quantities of biologic drugs, including vaccines, syringes, and other injectable biologics. Their ability to provide effective protection during transportation and storage is a key factor driving this segment’s growth.
The ampoule segment held the dominant market share in 2023 and is expected to maintain its leadership during the forecast period. Ampoules are widely used for storing temperature-sensitive biologic drugs such as vaccines and injectables, as they provide a sterile and secure environment for biologics. The demand for ampoules in secondary packaging solutions is driven by the need for safe, sterile, and temperature-controlled packaging for biologics.
The biologics CDMO secondary packaging market is poised for significant growth due to the rapid advancements in the biopharmaceutical sector. The rise in demand for vaccines, gene therapies, and biologics, driven by increasing healthcare needs and changing disease patterns, presents a major opportunity for the market. Additionally, the continued outsourcing of biologic drug manufacturing to CDMOs opens up avenues for growth, as these organizations are well-positioned to provide cost-effective and efficient packaging solutions.
The shift toward sustainable and eco-friendly packaging materials further enhances the market’s potential. As environmental concerns become more prominent, the biologics CDMO secondary packaging market is increasingly adopting recyclable and biodegradable materials, offering a greener alternative to traditional packaging.
Invest in Our Premium Strategic Solution: https://www.towardspackaging.com/price/5363
Get the latest insights on packaging industry segmentation with our Annual Membership – https://www.towardspackaging.com/get-an-annual-membership
If you have any questions, please feel free to contact us at sales@towardspackaging.com
Browse our Brand-New Journal:
https://www.towardshealthcare.com
https://www.towardsautomotive.com
For Latest Update Follow Us: https://www.linkedin.com/company/towards-packaging/
Get Our Freshly Printed Chronicle: https://www.packagingwebwire.com/
The drugs glass packaging market has seen significant growth in recent years and is expected…
The cartoning machines market has shown impressive growth and is poised to continue its upward…
The anti-static packaging market is set to experience significant growth in the coming years, with…
The ampule sticker labelling machine market is experiencing significant growth, poised for a surge in…
The global Electrostatic Discharge (ESD) packaging market reached a value of US$ 2.15 billion in…
The global laminated can packaging market reached a valuation of USD 2.40 billion in 2023…